Lantus Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

A Clinical Efficacy and Safety Study of Insulin Glargine U300 in Chinese Adult Patients With Uncontrolled Type 2 Diabetes Mellitus With a 3-month Extension Period
Condition:   Type 2 Diabetes Mellitus Intervention:   Drug: Insulin glargine 300 U/ml Sponsor:   Sanofi Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 12, 2021 Category: Research Source Type: clinical trials

Evaluation of the Safety and Efficacy of Insulin Glargine 300 U/ml (Gla-300) in Insulin-na ïve Patients With Type 2 Diabetes Mellitus Uncontrolled on Oral Antihyperglycemic Drugs
Condition:   Type 2 Diabetes Mellitus Intervention:   Drug: Insulin glargine (U300) Sponsor:   Sanofi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2021 Category: Research Source Type: clinical trials